"$70 million Series C funding secured by Nabla, for deployment of autonomous AI in clinical workflows; grand total funding now stands at $120 million"

Nabla, a leading AI company, has announced the successful completion of its Series C funding round, raising $70 million. The funding round was led by HV Capital, with Highland Europe joining as a key investor. DST Global, Cathay Innovation, and Tony Fadell's Build Collective also participated in the funding.

The new capital will be used to accelerate product development, team expansion, and strategic partnerships. This investment comes as Nabla continues to make significant strides in the healthcare industry, with its AI assistant supporting over 85,000 clinicians and handling more than 20 million annual encounters.

Nabla's customer success model is built on responsiveness and rapid iteration. Health system partners cite hands-on support, real-time feedback loops, streamlined onboarding, high adoption rates, and strong alignment with clinical workflows as key drivers of adoption and sustained use.

With the fresh infusion of funds, Nabla is expanding its AI assistant to support coding, agentic EHR commands, and a wider range of clinical roles. The Context-Aware Agent will expand its use of historical data to introduce smarter documentation, initiate orders, and direct EHR commands. Nabla is also deploying new capabilities tailored for nurses and expanding into inpatient environments and other frontline roles.

Peer-reviewed studies from University of Iowa Health Care and real-world data from Denver Health confirm significant reductions in clinician burnout and a 15-point increase in patient satisfaction. The platform is increasingly used in rural hospitals, FQHCs, and children's hospitals, demonstrating its versatility and applicability across various healthcare settings.

Nabla's assistant is available in 35 languages, making it accessible to a global audience. The platform integrates with Epic, Cerner, athenahealth, NextGen, Greenway, and other major EHRs and is built on a privacy-first model.

Nabla's AI assistant is now embedded in over 130 healthcare organizations across the U.S., including major academic medical centers, safety-net hospitals, community health centers, and physician groups. Leading systems and providers such as CVS Health, Children's Hospital Los Angeles, Carle Health, Denver Health, and University of Iowa Health Care are among its users.

The Proactive Coding Agent will improve real-time support for ICD-10, HCC, and MCC coding, with upcoming features for E/M coding and compliance nudges. Nabla is a member of the Coalition for Health AI, further solidifying its commitment to advancing AI in healthcare.

In 2025, the Mayo Clinic in the United States adopted Nabla as one of its AI assistants for clinical workflows. This partnership underscores Nabla's growing influence and acceptance in the healthcare industry.

As Nabla continues to grow and evolve, it remains dedicated to refining its assistant over several years using clinically grounded data and a robust evaluation framework. The company's goal is to continue providing a responsive, effective, and user-friendly AI solution that enhances the efficiency and quality of healthcare delivery.

"$70 million Series C funding secured by Nabla, for deployment of autonomous AI in clinical workflows; grand total funding now stands at $120 million"